AnswersPublished15 sources
CRISPR-KOALA Uncovers 81 New Genes Driving Basal-Like Triple-Negative Breast Cancer, Opening New Avenues for Targeted Treatments
Using a new gene editing tool called CRISPR KOALA, researchers at the Lunenfeld Tanenbaum Research Institute (Sinai Health, Toronto) identified 81 previously unknown genes that drive basal like triple negative breast... CRISPR KOALA overcomes a major limitation of standard CRISPR screening by being able to both acti...
AI Prompt
openai.comCreate a landscape editorial hero image for this Studio Global article: Search & fact-check with cited sources for What did a team of scientists at Sinai Health in Toronto discover about basal-like triple-negativ. Article summary: A team of scientists at the Lunenfeld-Tanenbaum Research Institute, part of Sinai Health in Toronto, developed a new gene-editing tool called **CRISPR-KOALA** and used it to identify **81 previously unknown genes that dr. Topic tags: general, government, academic, general web, user generated. Style: premium digital editorial illustration, source-backed research mood, clean composition, high detail, modern web publication hero. Use reference image context only for broad subject, composition, and topical grounding; do not copy the exact image. Avoid: logos, brand marks, copyrighted characters, real person likenesses, fake screenshots, UI text, readable text, wate
A team of scientists at the Lunenfeld-Tanenbaum Research Institute, part of Sinai Health in Toronto, has developed a powerful new gene-editing tool called CRISPR-KOALA and used it to identify 81 previously unknown genes that drive basal-like triple-negative breast cancer (TNBC). The breakthrough was published in the journal Nature around July 2026, and it represents a major step forward in understanding and potentially treating one of the most aggressive forms of breast cancer .
What is Basal-Like Triple-Negative Breast Cancer?
Triple-negative breast cancer (TNBC) is a subtype of breast cancer that does not express the estrogen receptor (ER), progesterone receptor (PR), or the HER2 protein . The
Studio Global AI
Search, cite, and publish your own answer
Use this topic as a starting point for a fresh source-backed answer, then compare citations before you share it.
People also ask
What is the short answer to "CRISPR-KOALA Uncovers 81 New Genes Driving Basal-Like Triple-Negative Breast Cancer, Opening New Avenues for Targeted Treatments"?
Using a new gene editing tool called CRISPR KOALA, researchers at the Lunenfeld Tanenbaum Research Institute (Sinai Health, Toronto) identified 81 previously unknown genes that drive basal like triple negative breast...
What are the key points to validate first?
Using a new gene editing tool called CRISPR KOALA, researchers at the Lunenfeld Tanenbaum Research Institute (Sinai Health, Toronto) identified 81 previously unknown genes that drive basal like triple negative breast... CRISPR KOALA overcomes a major limitation of standard CRISPR screening by being able to both activate and silence genes within the same animal model, allowing researchers to systematically test thousands of genes in l...
What should I do next in practice?
The team screened over 3,700 genes and found that 90% of the 81 cancer promoting genes had been completely missed by prior large scale cancer genomics studies.
Sources
- sinaihealth.caDrucker-Reitman Families Innovation Awards celebrate trainees ...
- sinaihealth.caHow award-winning research trainees are transforming our ...
- libertaddigital.comLogro contra el cáncer de mama basal: identifican 81 genes gracias a la técnica CRISPR
- pmc.ncbi.nlm.nih.govA hallmark for triple-negative breast cancer therapeutics advancement
- nature.comComprehensive molecular portraits of human breast tumours - Nature
- pmc.ncbi.nlm.nih.govApplications of CRISPR Technology to Breast Cancer and Triple ...
- pmc.ncbi.nlm.nih.govCRISPR/Cas9 as a therapeutic tool for triple negative breast cancer
- sciencedirect.comExploring the potential of CRISPR in triple-negative breast ...
- cedars-sinai.orgCedars-Sinai Newsroom | Health Breakthroughs & Expert News
- cancercareontario.caComprehensive Cancer Biomarker Testing Program – As of June 1 ...
- mountsinai.orgtriple-negative breast cancer - Mount Sinai
- ijhsr.org[PDF] Review of Current Applications of CRISPR Gene Editing Techniques ...
- biorxiv.org96133651
- pnas.orgIn vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer | PNAS
- nrc.canada.caThe NRC H.L. Holmes Award supports the development of technology to target and treat basal-like breast cancer